ICD-10 Coding for Metastatic Lung Cancer(C34.0, C34.1, C34.9)
Comprehensive guide to ICD-10 coding for metastatic lung cancer, including primary and secondary site codes, documentation requirements, and common pitfalls.
Complete code families applicable to Metastatic Lung Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.9 | Malignant neoplasm of unspecified part of bronchus or lung | Use when lung cancer is the primary site and specific lobe is not specified. |
|
| C78.00 | Secondary malignant neoplasm of lung, unspecified | Use when the lung is a secondary site of metastasis. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMetastatic Lung Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Metastatic Lung Cancer.
Ambiguous documentation of metastatic sites
Impact
Clinical: Leads to misinterpretation of cancer staging., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Use specific terminology for primary and secondary sites, Regular training on documentation standards
Using C34.9 for metastatic to lung
Impact
Reimbursement: Incorrect DRG assignment leading to financial discrepancies., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use C78.00 for secondary lung involvement.
Incorrect sequencing of codes
Impact
Primary and secondary sites not properly sequenced.
Mitigation
Regular audits and training on coding guidelines.